Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12109258
Synthetic malaria immunogens, combinations thereof, and their use to prevent and treat malaria infections
granted -
US 12109224
USB1 directed regulation of miRNAs related hematopoietic differentiation and affected in multiple forms of leukemia
granted -
US 12109231
Treatment of neurodegenerative disease with sodium chlorite
granted -
US 12109198
Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
granted -
US 12109225
Methods for potentiating cancer treatment using ionizing radiation
granted -
US 12110315
Fish-derived peptidoglycan recognition protein mutant and application thereof
granted -
US 12110334
Neutralizing antibodies to the αvβ8 integrin complex for immunotherapy
granted -
US 12108745
Rat model of IgA nephropathy induced with a multimeric recombinant IgA fragment
granted -
US 12109229
Treatment of neurodegenerative disease with sodium chlorite
granted -
US 12110343
Anti-plasma kallikrein antibodies
granted -
US 12109260
Zika vaccines and immunogenic compositions, and methods of using the same
granted -
US 12109239
Methods for production of human hemogenic endothelial cells from pluripotent stem cells and compositions thereof
granted -
US 12109216
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted -
US 12109230
Treatment of neurodegenerative disease with sodium chlorite
granted -
US 12110504
Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes
granted -
US 12109272
Intermittent dosing of glucocorticoid receptor modulators for the treatment of ovarian and other cancers
granted -
US 12109296
Peptide exhibiting wrinkle-improving activity and uses thereof
granted -
US 12110492
RNAi agents for inhibiting expression of complement component C3 (C3), pharmaceutical compositions thereof, and methods of use
granted -
US 12109196
Non-sedating dexmedetomidine treatment regimens
granted -
US 12110502
Models of tauopathy
granted -
US 12110520
PH20 polypeptide variants, formulations and uses thereof
granted -
IT 202300006237
COMPOSIZIONI NUTRACEUTICHE PER IL TRATTAMENTO O PREVENZIONE DI DISORDINI CONNESSI ALLA TRIMETILAMINURIA.
granted -
PT 3721882
TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS
granted -
US 2024327366
POLYMORPH FORM OF PITOLISANT HYDROCHLORIDE
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.